Abstract
Advances in drug design have led to the development of new drug molecules peptides, and proteins. However, the limited ability to deliver selectively these molecules at well-defined dosing regimens remains a significant challenge. Therefore, new materials and manufacturing techniques are emerging, with the ability to meet the challenges associated with the formulation and delivery of biopharmaceuticals and pharmaceuticals.
Original language | English |
---|---|
Specialist publication | Bioprocess Online |
Publication status | Published - 28 Jun 2021 |
Keywords
- 3D Printing
- Bioprinting
- Microfluidics
- Electrospinning
- Proteins
- Peptides